Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial
Open Access
- 4 April 2012
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 12 (1) , 44
Abstract
The Estonian Postmenopausal Hormone Therapy (EPHT) Trial assigned 4170 potential participants prior to recruitment to blind or non-blind hormone therapy (HT), with placebo or non-treatment the respective alternatives. Before having to decide on participation, women were told whether they had been randomised to the blind or non-blind trial. Eligible women who were still willing to join the trial were recruited. After recruitment participants in the non-blind trial (N = 1001) received open-label HT or no treatment, participants in the blind trial (N = 777) remained blinded until the end of the trial. The aim of this paper is to analyse the effect of blinding on internal and external validity of trial outcomes.Keywords
This publication has 26 references indexed in Scilit:
- Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]BJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Postmenopausal hormone therapy increases use of health services: Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]American Journal of Obstetrics and Gynecology, 2006
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapyJournal of Clinical Epidemiology, 2004
- Study of completeness of registration at the Estonian cancer registryEuropean Journal Of Cancer Prevention, 2003
- Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trialClimacteric, 2003
- Statistics Notes: Blinding in clinical trials and other studiesBMJ, 2000
- Patients' preferences and randomised trialsThe Lancet, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Randomisation.BMJ, 1991